|
|
||||||||
CUTTING EDGE |
Department of Immunology, Duke University Medical Center, Durham, NC 27710
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Lipid rafts have also been implicated to play a critical role in immune receptor signaling (4, 5). In TCR-mediated signaling pathways, many signaling proteins have been found in lipid rafts; one such protein is the adaptor protein, linker for activation of T cells (LAT)3 (6, 7). LAT is palmitoylated and constitutively localized in lipid rafts (8). Palmitoylation of LAT is essential for its localization to lipid rafts, tyrosine phosphorylation, and function in TCR signaling (8).
In addition to proteins that are constitutively localized in lipid rafts, other signaling proteins, such as the TCR/CD3 complexes, are recruited to lipid rafts after T cell activation (9). Because lipid rafts contain many signaling proteins, they are postulated to function as essential platforms to initiate signaling cascades. However, despite widespread acceptance of the fundamental role of rafts in immunoreceptor signaling, the very existence of rafts remains a topic of debate (10). Detergent extraction of membranes could induce formation of nonphysiological structures. Proteins might be extracted from the membrane based on their physical properties, such as insolubility in Triton, rather than their real distribution on the plasma membrane (10). Depletion of cholesterol by methyl-
-cyclodextrin, one method to used to demonstrate the importance of lipid rafts, could alter the physical properties of cellular membranes such as permeability and fluidity (11, 12); thus, the effects on TCR signaling by cholesterol depletion do not prove that rafts or protein localization to rafts is essential in T cell activation.
Because LAT plays an essential role in T cell activation, likely by nucleating signaling complexes in lipid rafts to transmit signals from the TCR to the Ras-MAPK and Ca2+ pathways, we chose to study the role of lipid rafts in T cell activation by targeting LAT to nonraft fractions and then examine whether T cell activation still proceeds normally. Our results indicate that LAT localization to lipid rafts is not essential in LAT-mediated signaling and function during T cell activation.
| Materials and Methods |
|---|
|
|
|---|
The pMSCV and pCEFL constructs, used to reconstitute LAT-deficient cells, expressed a linker for activation of X cells (LAX)-LAT fusion protein comprising the extracellular and transmembrane domains of human LAX (residues 168) and the cytoplasmic domain of human LAT (residues 35233). The LAX-LAT fusion protein in the transgenic construct contained human LAX (residues 168) and the cytoplasmic domain of murine LAT (residues 36242).
Antibodies
The following Abs were used in the experiments: anti-human CD3
(OKT3), human TCR (C305), myc (9E10), anti-LAT (6), phosphotyrosine (PY-20), and Grb2 (BD Pharmingen); phosphotyrosine (4G10), LATpY191, and PLC-
1 (Upstate Biotechnology); pErk (Cell Signaling, Beverly, MA); and CD3, CD28, FITC-CD4, allophycocyanin-CD8, and PE-TCR
(eBioscience, San Diego, CA).
T cell activation, immunoprecipitation, and Western blot
MAPK activation, Ca2+ flux, and luciferase assay in Jurkat cells were performed as previously described (13). Lipid raft and nonraft fractions were separated on sucrose gradients (8). Jurkat cells (1 x 108 cells/ml) were stimulated with anti-TCR Abs (C305) for 1.5 min before lysis. Thymocytes and splenocytes were incubated with biotinylated anti-CD3 (5 µg/ml) and CD4 (1 µg/ml) Abs, followed by cross-linking with streptavidin (25 µg/ml). For Ca2+ flux in primary T cells, thymocytes, and splenocytes were loaded with indo-1 for 30 min and then stained with PE-CD4. After addition of biotinylated anti-CD3 (5 µg/ml) and CD4 (1 µg/ml) Abs followed by streptavidin cross-linking (25 µg/ml), Ca2+ flux was analyzed by flow cytometry.
For anti-CD3 and -CD28-mediated IL-2 production and T cell proliferation, purified CD4+ T cells were stimulated with plate-bound anti-CD3 alone at 1 and 10 µg/ml or anti-CD3 (1 µg/ml) and anti-CD28 (1, 5, and 10 µg/ml). Twenty hours after stimulation, the supernatants were used in ELISA to quantitate IL-2 concentration, and [3H]thymidine was added for 68 h. Incorporation of thymidine was measured by a liquid scintillation counter.
For Western blotting, samples were separated by SDS-PAGE and transferred onto nitrocellulose. After incubation with primary Abs, nitrocellulose membranes were washed three times and probed with either anti-mouse or -rabbit Ig-conjugated to Alexa Fluor 680 (Molecular Probes) or IRDye800 (Rockland). Membranes were then analyzed and relative levels of LAX-LAT and LAT proteins were quantitated by Odyssey infrared imaging system (LI-COR, Lincoln, NE).
NP-specific Ab response
For T-dependent Ab response, 5- to 8-wk-old mice were immunized i.p. with 50 µg of alum-precipitated nitrophenylacetyl chicken
-globulin (NP-CGG) and challenged with 50 µg of NP-CGG with alum at day 21. Sera were collected at different time points after immunization. Nitrophenylacetyl (NP)-specific IgG1 production was determined by ELISA. High-affinity NP-specific Abs were measured on plates coated with NP5-BSA. Total NP-specific Abs were measured on plates coated with NP25-BSA.
| Results |
|---|
|
|
|---|
|
To determine whether the LAX-LAT protein could be phosphorylated upon T cell activation, cells expressing LAT or LAX-LAT were activated with anti-TCR Abs, and cell lysates were subjected to immunoprecipitation. As shown in Fig. 1C, both the LAT and LAX-LAT proteins were highly phosphorylated upon T cell activation, even though LAX-LAT was not localized to lipid rafts. This result indicated that LAT localization to lipid rafts is not essential for its phosphorylation.
We next examined whether the LAX-LAT protein could interact with Grb2 and PLC-
1, two proteins that the WT LAT binds after TCR engagement. Grb2 and PLC-
1 were immunoprecipitated and analyzed by Western blotting with anti-pTyr Abs. As shown in Fig. 1C, anti-Grb2 and -PLC-
1 Abs coprecipitated phosphorylated LAT and LAX-LAT. Thus, the LAT-LAX protein can associate with Grb2 and PLC-
1 as efficiently as the WT LAT.
We then determined whether the LAX-LAT protein could restore TCR signaling in J.CaM2.5 cells. Twenty-four hours after retroviral transduction, GFP+ cells were sorted by flow cytometry and were expanded. After stimulation with anti-TCR Abs or left untreated, total lysates were analyzed by Western blotting with anti-active Erk (pErk). As shown in Fig. 1D, Erk activation in LAT-deficient cells was restored by either LAT or LAX-LAT, indicating that this fusion protein is able to function in TCR-mediated Erk activation. We also investigated whether LAX-LAT could reconstitute TCR-mediated Ca2+ flux in LAT-deficient cells. Twenty-four hours after retroviral transduction, LAT-deficient cells were loaded with the calcium indicator indo-1 and analyzed by flow cytometry. The anti-human CD3
mAb (OKT3) was used to induce Ca2+ flux in these cells. As shown in Fig. 1E, Ca2+ flux in J.CaM2.5 cells was restored by both LAT and LAX-LAT. We further examined whether this fusion protein could function in TCR-mediated NFAT activation by transfecting LAT-deficient cells with plasmids expressing either LAT or LAX-LAT together with NFAT/AP-1 luciferase. As reported (6, 7), NFAT activation in LAT-deficient cells (ANJ3) was restored by introduction of WT LAT. LAX-LAT was equally competent in the restoration of TCR-mediated NFAT activation (Fig. 1F). Collectively, these results indicated that the LAX-LAT protein, although not localized to lipid rafts, is phosphorylated upon TCR engagement, interacts with Grb2 and PLC-
1, and functions in Ras-MAPK activation, Ca2+ flux, and NFAT activation.
To this point, we have demonstrated that the LAX-LAT fusion protein was indistinguishable from the WT LAT when it was tested in LAT-deficient Jurkat cells. Can LAX-LAT also function in vivo to support thymocyte development and normal T cell activation? Transgenic mice were generated that express the LAX-LAT protein under the control of the CD2 promoter; this promoter successfully drives expression of transgenes in T cells (15). Transgenic mice were crossed with LAT/ mice to generate a LAT/Tg+ strain. As shown in Fig. 2A, the LAX-LAT transgene fully rescued thymocyte development in LAT/ mice. CD4+CD8+ (double-positive) and CD4+ and CD8+ (single-positive) thymocytes appeared in thymuses from LAT/Tg+ mice. Mature single-positive T cells were also found in spleens from these mice. The percentage of each population in LAT/Tg+ mice was similar to that in LAT+/ mice. Transgenic T cells expressed normal levels of TCR
chain on their cell surface (data not shown).
|
TCR-mediated phosphorylation of cellular proteins proceeded normally in T cells from LAT/Tg+ mice (Fig. 2D). Upon activation of thymocytes and splenocytes by cross-linking of CD3 and CD4, both LAT and LAX-LAT proteins were phosphorylated as detected by Western blotting with Abs against pTyr and phosphorylated LAT at Y191 (LATpY191). Although most of the phosphorylated LAT was localized to rafts as previously reported (8), phosphorylated LAX-LAT was exclusively found in nonraft fractions (data not shown). We also examined TCR-mediated Erk activation and Ca2+ mobilization in thymocytes and splenocytes. We did not observe any significant differences between cells from WT and LAT/Tg+ mice (data not shown and Fig. 3A).
|
Finally, we investigated whether T cells from the LAT/Tg+ mice function normally in vivo. LAT/Tg+ and WT mice were immunized with a T-dependent Ag, NP-CGG, and then challenged 21 days later with a second dose of NP-CGG. NP-specific Ab titers were assayed by ELISA. Production of NP-specific IgG1, including high-affinity anti-NP IgG1, was virtually the same in these mice (Fig. 3D). T cells from LAT/Tg+ mice, like those from control mice are fully capable of helping B cells undergo isotype switching and affinity maturation to produce high-affinity IgG1 Abs, indicating that the LAX-LAT protein functions indistinguishably from the WT LAT in T-dependent Ab response in vivo.
| Discussion |
|---|
|
|
|---|
The physiological role and even the existence of lipid rafts remain controversial. Visualization of lipid rafts in vivo yielded conflicting results (10). Detergent extraction, which is normally used to identify lipid rafts biochemically, could possibly induce aggregation of structures that do not exist before extraction. Depletion of cholesterol could certainly cause changes in plasma membrane such as membrane permeability and fluidity (10). Interestingly, depletion of cholesterol with methyl-
-cyclodextrin at a low concentration that is sufficient to disrupt rafts has no effect on TCR-mediated tyrosine phosphorylation (16). Our results are in line with those findings and further demonstrated whether lipid rafts, specifically LAT localization to lipid rafts, is important in TCR-mediated MAPK activation, calcium flux, NFAT activation, and IL-2 production. Although we cannot exclude the possibility that the LAX-LAT transiently or loosely associates with rafts, our data show that, even though the LAX-LAT protein is not detected in lipid rafts, it is fully functional in T cell activation and development. Thus, LAT-mediated signaling cascades, including Ras-MAPK activation and Ca2+ flux, do not have to be initiated from lipid rafts. Although our results here do not address the importance or existence of lipid rafts directly, they raised the possibility that lipid rafts may not be fundamental in T cell activation.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 This work was supported by National Institutes of Heath Grants AI048674 and AI056156. ![]()
2 Address correspondence and reprint requests to Dr. Weiguo Zhang, Department of Immunology, Jones Building, Room 112, Box 3010, Duke University Medical Center, Durham, NC 27710. E-mail address: zhang033{at}mc.duke.edu ![]()
3 Abbreviations used in this paper: LAT, linker for activation of T cells; LAX, linker for activation of X cells; NP, nitrophenylacetyl; NP-CGG, nitrophenylacetyl chicken
-globulin; WT, wild type. ![]()
Received for publication August 31, 2004. Accepted for publication October 20, 2004.
| References |
|---|
|
|
|---|
1 and the Ras pathway. Immunity 9:617.[Medline]
and
transgenes on early
/
T cell development. J. Exp. Med. 179:1485.This article has been cited by other articles:
![]() |
D. Beach, R. Gonen, Y. Bogin, I. G. Reischl, and D. Yablonski Dual Role of SLP-76 in Mediating T Cell Receptor-induced Activation of Phospholipase C-{gamma}1 J. Biol. Chem., February 2, 2007; 282(5): 2937 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Resh Palmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules Sci. Signal., October 31, 2006; 2006(359): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kliche, D. Breitling, M. Togni, R. Pusch, K. Heuer, X. Wang, C. Freund, A. Kasirer-Friede, G. Menasche, G. A. Koretzky, et al. The ADAP/SKAP55 Signaling Module Regulates T-Cell Receptor-Mediated Integrin Activation through Plasma Membrane Targeting of Rap1. Mol. Cell. Biol., October 1, 2006; 26(19): 7130 - 7144. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |